LON:BPCR BioPharma Credit (BPCR) Share Price, News & Analysis GBX 0.89 +0.01 (+0.68%) As of 05/13/2025 12:40 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsDividendInsider TradesBuy This Stock About BioPharma Credit Stock (LON:BPCR) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get BioPharma Credit alerts:Sign Up Key Stats Today's Range 0.89▼ 0.9050-Day Range 0.80▼ 0.8952-Week Range 0.80▼ 0.94Volume950,818 shsAverage Volume906,001 shsMarket Capitalization£1.05 billionP/E Ratio10.09Dividend Yield788.29%Price TargetN/AConsensus RatingN/A Company OverviewBioPharma Credit PLC, an investment trust, primarily invests in interest-bearing debt assets. Its debt assets are secured by royalties or other cash flows derived from the sales of approved life sciences products. The company was incorporated in 2016 and is based in London, the United Kingdom.Read More… Receive BPCR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for BioPharma Credit and its competitors with MarketBeat's FREE daily newsletter. Email Address BPCR Stock News HeadlinesCash in on the biotech sector with specialist trust BioPharmaApril 3, 2025 | msn.comBioPharma Credit announces dividend payoutJanuary 23, 2025 | msn.comElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they gotten away with it, the Fed and U.S. banks could have seized control of our financial lives forever. But Trump stopped them cold on January 23rd, 2025, when he outlawed CBDCs… Paving the way for Elon Musk's secret master plan.May 14, 2025 | Brownstone Research (Ad)BioPharma Credit's (LON:BPCR) investors will be pleased with their respectable 43% return over the last five yearsJanuary 7, 2025 | finance.yahoo.comInvestors in BioPharma Credit (LON:BPCR) have seen respectable returns of 44% over the past five yearsAugust 1, 2024 | finance.yahoo.comBuy Rating Affirmed for Benitec Biopharma Following Promising BB-301 Trial Results and Financial BoostApril 22, 2024 | markets.businessinsider.comBioPharma Credit PLC (BPCP.L)February 26, 2024 | nz.finance.yahoo.comInvestors in BioPharma Credit (LON:BPCR) have seen notable returns of 40% over the past five yearsFebruary 22, 2024 | finance.yahoo.comSee More Headlines BPCR Stock Analysis - Frequently Asked Questions How have BPCR shares performed this year? BioPharma Credit's stock was trading at GBX 0.88 on January 1st, 2025. Since then, BPCR stock has increased by 0.5% and is now trading at GBX 0.89. View the best growth stocks for 2025 here. How do I buy shares of BioPharma Credit? Shares of BPCR stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What other stocks do shareholders of BioPharma Credit own? Based on aggregate information from My MarketBeat watchlists, some other companies that BioPharma Credit investors own include AFPO.L (AFPO), Altius Minerals (ATUSF), LiDCO Group Plc (LID.L) (LID), NexGen Energy (NXE), Peninsula Energy (PEN), Premier African Minerals (PREM) and 21512 (SAT.L) (SAT). Company Calendar Record date for 3/13 Dividend2/06/2025Ex-Dividend for 3/13 Dividend2/06/2025Dividend Payable3/13/2025Record date for 5/7 Dividend4/03/2025Ex-Dividend for 5/7 Dividend4/03/2025Dividend Payable5/07/2025Today5/13/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON SectorFinancial Services Industry Asset Management Sub-IndustryN/A Current SymbolLON:BPCR CIKN/A Webwww.bpcruk.com Phone44 13 9247 7500FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)GBX 0.09 Trailing P/E Ratio10.09 Forward P/E RatioN/A P/E GrowthN/ANet Income£10.42 billion Net Margins80.20% Pretax MarginN/A Return on Equity8.51% Return on Assets4.98% Debt Debt-to-Equity RatioN/A Current Ratio21.50 Quick Ratio14.07 Sales & Book Value Annual Sales£12.99 billion Price / Sales0.08 Cash FlowGBX 0.74 per share Price / Cash Flow1.19 Book ValueGBX 98.56 per share Price / Book0.01Miscellaneous Outstanding Shares118,721,336,824Free FloatN/AMarket Cap£1.05 billion OptionableNot Optionable Beta0.22 The Best High-Yield Dividend Stocks for 2025Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free Report This page (LON:BPCR) was last updated on 5/14/2025 by MarketBeat.com Staff From Our PartnersGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredTrump’s betrayal exposed Trump’s third-term comments grabbed headlines, but the bigger story is what he’s planning next. A new report ...Porter & Company | SponsoredSilver Demand Is Soaring-Supply Can't Keep UpSilver demand hit 1.16 billion ounces in 2024-while supply fell short again for the fourth year in a row. I...i2i Marketing Group, LLC | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredBitcoin Just Broke $100K – Are You Positioned?This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredA New Economic Shift – How You Can PrepareWhile everyone's focused on the Fed and interest rates... most investors are missing the real story. There'...InvestorPlace | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioPharma Credit Please log in to your account or sign up in order to add this asset to your watchlist. Share BioPharma Credit With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.